Janux Therapeutics, Inc. (JANX): Total Assets
$1.00B
As of 2025-12-31
$1.01B
As of 2026-06-30
+40.1%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.00B | -5.6% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $1.06B | +179.0% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $380.41M | +4.5% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $364.01M | -4.2% | 2024-03-08, Balance as of period end |
| 2021-12-31 | $379.82M | n/m | 2023-03-10, Balance as of period end |
| 2020-12-31 | $16.22M | n/a | 2022-03-18, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | 2025-12-31 | $1.00B | -5.6% |
| Zenas BioPharma, Inc. (ZBIO) | 2025-12-31 | $383.64M | +3.7% |
| Precigen, Inc. (PGEN) | 2025-12-31 | $155.50M | +7.0% |
| Prothena Corp Public Ltd Co (PRTA) | 2025-12-31 | $326.80M | -40.3% |
| Crescent Biopharma, Inc. (CBIO) | 2025-12-31 | $240.29M | +574.7% |
| International Stem Cell Corp (ISCO) | 2025-12-31 | $4.82M | -6.8% |
| BioAge Labs, Inc. (BIOA) | 2025-12-31 | $294.89M | -17.7% |
| Jaguar Health, Inc. (JAGX) | 2025-12-31 | $38.32M | -28.3% |
| Roivant Sciences Ltd. (ROIV) | 2026-03-31 | $5.71B | +5.0% |
Compare JANX, ZBIO, PGEN, PRTA side by side · Screen every company in Pharmaceutical Preparations ↗